FDA Alert Articles

New Treatment for Schizophrenia and Bipolar Disorder

Friday, August 14th, 2009
The U.S. Food and Drug Administration (FDA) has approved Saphris tablets (asenapine) to treat adults with schizophrenia or bipolar disorder. "Mental illnesses ...

Invega Antipsychotic Approved for Schizophrenia, Schizoaffective Disorder

Thursday, August 6th, 2009
Last week, the U.S. Food and Drug Administration (FDA) handed down two new approvals for Invega (paliperidone), an atypical antipsychotic medication, ...

Once-Daily Trazodone Rejected by FDA

Monday, July 20th, 2009
A once-daily form of trazodone, a second-generation antidepressant that has been available for the treatment of depression for decades, ...

Chantix, Zyban Users Warned of Risk of Suicide, Depression

Wednesday, July 1st, 2009
The U.S. Food and Drug Administration today announced that it is requiring manufacturers to put a Boxed Warning ...

FDA Urges Caution on Heart Findings from ADHD Drug Study

Monday, June 15th, 2009
The U.S. Food and Drug Administration (FDA) urged caution on interpreting the findings from a new study published ...

FDA Panel Recommends Approval of Seroquel, Geodon and Zyprexa for Children, Teens

Wednesday, June 10th, 2009
Three atypical antipsychotics -- Seroqiel, Geodon, and Zyprexa -- were voted to be “acceptably safe” ...

FDA Panel Recommends Approval of Seroquel for Teens

Wednesday, June 10th, 2009
Seroquel was voted to be "acceptably safe" and effective for the treatment of schizophrenia in teenagers, said a U.S. Food ...

FDA Warnings Influence Depression Diagnosis

Tuesday, June 2nd, 2009
A review of a government decision to issue a warning for children taking antidepressants suggests unintended consequences. Government warnings about suicidality among children ...

Risperdal Consta Approved for Bipolar

Monday, May 18th, 2009
Risperdal Consta (risperidone), a drug already approved in the treatment of schizophrenia, has received approval by the U.S. Food and Drug Administration (FDA) ...

FDA Approves Fanapt for Treatment of Schizophrenia

Thursday, May 7th, 2009
The U.S. Food and Drug Administration (FDA) yesterday approved a new psychiatric medication for the treatment of adults with schizophrenia called ...